Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Updates on acquisition of Laurus Bio Shares16-10-2023
16-10-2023
Laurus Labs Ltd - 540222 - Immunoact Announces The Approval Of India'S First CAR-T Cell Therapy, Nexcar19 (Actalycabtagene Autoleucel), For The Treatment Of R/R B-Cell Lymphomas And Leukemia From The Central Drugs Standard Control Organization (CDSCO)
Disclosure under Regulation 30 of SEBI (LODR)13-10-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed the Q2 & 1H FY 24 Earnings conference call invite for the call scheduled on October 20, 2023 at 04.00 PM (IST).13-10-2023
Laurus Labs Ltd - 540222 - Board Meeting Intimation for 1) Considering The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023; 2) Considering The Proposal For Payment Of Interim Dividend For FY 2023-24. 3) Other Matters
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2023 ,inter alia, to consider and approve 1) the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2023 2) the proposal for payment of Interim Dividend for FY 2023-24 3) other matters13-10-2023
Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations for September quarter09-10-2023
Laurus Labs Ltd - 540222 - Closure of Trading Window
Closure of trading window for Q2 FY 2023-2429-09-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
J.P. Morgan India Investor Summit 202320-09-2023
Laurus Labs sinks 6% after Kotak Institutional Equities downgrades rating to 'sell'
Laurus Labs' Synthesis segment is currently trading at a premium of more than 25 percent higher than Syngene. Considering the significant differences in their capabilities and size, the brokerage firm finds it hard to justify this premium.12-09-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition updates11-09-2023
Laurus Labs Ltd - 540222 - Board Meeting Outcome for Outcome Of The Board Meeting Dated September 11, 2023
Outcome of the Board Meeting dated September 11, 202311-09-2023